Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Kapsokavathis

Orthopaedic Surgery of the Spine Birmingham, MI Doctor of Osteopathy

NPI 1568664134 CMS profile 297646

700 N Old Woodward Ave, Suite 150, Birmingham, MI 48009

Open in the dashboard

General payments

$120,487

87 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Kapsokavathis of Birmingham, MI is reported in the CMS Open Payments database as having received $120,487 across 87 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,303 13
2024 General $844 10
2023 General $7,635 20
2022 General $31,087 20
2021 General $21,667 8
2020 General $23,982 3
2019 General $21,969 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Kapsokavathis
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Michael Kapsokavathis were reported at $13,303. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Michael Kapsokavathis Orthopaedic Surgery of the Spine median Middle half National median
2019 $21,969 $2,106 $337–$18,608 $163
2020 $23,982 $1,213 $156–$15,082 $114
2021 $21,667 $1,834 $271–$15,617 $132
2022 $31,087 $2,015 $320–$17,036 $149
2023 $7,635 $1,925 $336–$14,599 $160
2024 $844 $2,110 $341–$12,483 $164
2025 $13,303 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Spineart SA $86,534 9 payments
  2. Spineart USA Inc $14,256 22 payments
  3. SC Medica $7,525 2 payments
  4. Precision Spine, Inc. $5,275 6 payments
  5. Centinel Spine, LLC $2,742 8 payments
  6. Spine Wave, Inc. $1,268 5 payments
  7. Integrity Implants Inc. $1,197 16 payments
  8. Neo Spine USA Inc $673 6 payments
  9. Innovasis Inc $277 3 payments
  10. Providence Medical Technology, Inc. $229 3 payments
  11. Other $512 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $86,534 9 payments
  2. Travel and Lodging $21,262 19 payments
  3. Consulting Fee $6,500 5 payments
  4. Food and Beverage $6,191 54 payments
Products named General payments · program years 2019–2025
  1. Navigation $23,639 2 payments
  2. Scarlet AC Orthopedics $22,982 2 payments
  3. SCARLET AC-T - CERVICAL CAGE LORDOTIC $21,202 2 payments
  4. Scarlet AC Orthopedic Surgery $17,543 2 payments
  5. SCARLET AL-T $9,683 14 payments
  6. MD-VUE LATERAL ACCESS SYSTEM $4,069 3 payments
  7. PRODISC C VIVO $2,207 6 payments
  8. REFORM TI CT MODULAR MIS PEDICLE SCREW SYSTEM $2,069 2 payments
  9. Spinal Implants $1,268 5 payments
  10. PERLA C $1,168 1 payment
  11. Other $4,143 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

24

Median for Neurosurgery: 83

Drug cost

$210

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Methocarbamol Generic 11 $136
Mupirocin Generic 13 $74

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$29,366

Medicare's payments for the services billed

Medicare patients

30

Average age 73

Services billed

103

15 women, 15 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 57%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

87 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record